HOME >> BIOLOGY >> NEWS
JCI table of contents: June 21, 2007

Editor's Pick:A diet rich in omega-3 fatty acids may lower prostate cancer genetic risk

A diet rich in omega-3 polyunsaturated fatty acids found in certain fish or fish oil, nuts, seeds, and vegetable oils may help lower prostate cancer risk in individuals with a genetic predisposition to cancer. So conclude researchers from Wake Forest University School of Medicine in their study appearing online on June 21 in advance of publication in the July print issue of the Journal of Clinical Investigation.

While many genetic mutations are known to predispose to cancer, it has remained unclear whether dietary fat can modulate the risk of developing cancer in genetically predisposed individuals. Some studies suggest that a diet rich in omega-3 polyunsaturated fatty acids reduces cancer incidence. To determine the influence of fatty acids on prostate cancer risk in animals with a defined genetic predisposition to cancer, Yong Chen and colleagues studied Pten-knockout mice (which are predisposed to develop prostate tumors) and the effects on these mice of diets with defined levels of specific polyunsaturated fatty acids. The authors found that a nutritionally balanced diet high in omega-3 fatty acid reduced prostate tumor growth and increased survival in these animals, whereas omega-6 fatty acids had the opposite effects. Furthermore, introduction into the Pten-knockout mice of the enzyme omega-3 desaturase, which converts omega-6 to omega-3, reduced tumor growth in a manner similar to the omega-3 rich diet. The researchers went on to show that the effect of polyunsaturated fatty acids on prostate cancer development is mediated in part through cell death that is dependent on a protein known as Bad. Together, the data highlight the importance of the interaction between genes and diet in prostate cancer and imply a beneficial effect of omega-3 polyunsaturated fatty acids on delaying the onset of human prostate cancer. It will be interesting in future studies
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
21-Jun-2007


Page: 1 2 3 4 5 6 7

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 14, 2007
10. Food safety begins as vegetables grow
11. Turning the tables in chemistry

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/17/2019)... ... April 17, 2019 , ... USDM Life Sciences (USDM) announces that Jay Crowley, ... solutions for Creating a Sustainable Global UDI Compliance Strategy at the European UDI Forum ... , What device manufacturers did to comply with the US FDA UDI ...
(Date:4/16/2019)... Texas (PRWEB) , ... April 16, 2019 , ... ... collaboration between employers and search firms with over $2 billion in placement fees ... with applicant tracking and employee onboarding platform, ExactHire. , This strategic relationship ...
(Date:4/16/2019)... (PRWEB) , ... April 16, 2019 , ... ... its featured speakers for two signature events: The 2019 ISPE Biopharmaceutical Manufacturing ... on 20–21 June. Taking place in one of the most influential bio ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... April 09, 2019 , ... USDM ... capacity of life sciences organizations to accelerate innovation and maximize productivity, announces that ... the past 12 months. , USDM’s Cloud Assurance is a managed ...
(Date:4/9/2019)... (PRWEB) , ... April 09, 2019 , ... The ... incoming members of the Society's leadership team, including a new addition to the presidential ... five of their peers to join the Society's leadership team for a three-year term ...
(Date:4/8/2019)... ... 2019 , ... US Capital Global Securities , an affiliate of US ... the privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 has a pipeline of ... sexual dysfunction disorder and is ready to begin phase 2b trials. In phase 2a ...
(Date:4/4/2019)... ... April 02, 2019 , ... Biomeme, Inc. , a ... latest field-ready solution for performing PCR, RT-PCR, qPCR, and Isothermal tests called ... Rosland Franklin, an English chemist and X-ray crystallographer who made significant contributions to ...
Breaking Biology Technology:
Cached News: